A study performed by UCSD oncologist and CureMatch co-founder Dr. Razelle Kurzrock and colleagues looked at 57 breast cancer patients using next-generation sequencing (NGS), and found that no two were the same. A total of 216 somatic
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.